Clinical Trial Update: SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing SJ-0021 (Gonalef) with Fertinorm-P for ovulation induction in Japanese infertile women has completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Fertinorm-P (purified pituitary gonadotropin)
• Gonalef (follicle-stimulating hormone (recombinant))

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility, Ovulation Induction | Phase 3 | Status: COMPLETED | Results posted: 2012-02-24